Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir

Journal of Hepatology
Zobair M YounossiPatrick Marcellin

Abstract

New interferon-free anti-HCV regimens are highly efficacious with a favorable safety profile. We assessed health-related quality of life (HRQL) and work productivity in patients with different stages of hepatic fibrosis treated with sofosbuvir+ledipasvir. Four questionnaires [Chronic Liver Disease Questionnaire-HCV (CLDQ-HCV), Short Form-36 (SF-36), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Work Productivity and Activity Index:Specific Health Problem (WPAI:SHP)] were administered at baseline, during, and after treatment with sofosbuvir+ledipasvir+ribavirin or sofosbuvir+ledipasvir (ION-1,2,3 clinical trials). Metavir fibrosis stage was determined from pre-treatment liver biopsies. There were 1005 patients included (stage F0: n=94; F1: n=311; F2: n=301; F3: n=197; F4: n=102). At baseline, patients with more advanced fibrosis had more HRQL impairments, predominantly related to physical functioning (stage 0 vs. stage 4 by up to 0.126 on a normalized 0-1 scale p<0.0001). During and post-treatment, HRQL remained lower in patients with advanced fibrosis. After achieving sustained virologic response, significant improvements from baseline in most HRQL domains were observed regardless of fibrosis stage (by 0.0...Continue Reading

References

Jul 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J E WareG L Davis
Feb 24, 2001·Journal of Hepatology·J G McHutchisonUNKNOWN Hepatitis Interventional Therapy Group
Mar 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Brennan M R SpiegelFasiha Kanwal
Jun 7, 2005·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·L M Martin, Z M Younossi
Oct 21, 2005·Journal of Hepatology·Robert J FontanaUNKNOWN HALT-C Trial Group
Jan 2, 2007·Journal of Hepatology·Herbert L BonkovskyUNKNOWN HALT-C Trial Group
Feb 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair YounossiJohn Kincaid
Apr 5, 2007·Digestive Diseases and Sciences·Jillian KallmanZobair M Younossi
Jan 1, 2008·General Hospital Psychiatry·Susana Carolina Batista-NevesAngela Miranda-Scippa
Jul 24, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Lucas C QuarantiniRodrigo A Bressan
Mar 31, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Marc G GhanyUNKNOWN American Association for the Study of Liver Diseases
Apr 29, 2010·Current Gastroenterology Reports·Gary L Davis, William L Roberts
Aug 5, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jun SuPatricia Corey-Lisle
Sep 28, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ira M JacobsonZobair M Younossi
Jan 19, 2011·Liver International : Official Journal of the International Association for the Study of the Liver·Alfredo Alberti
Mar 10, 2011·Journal of Medical Economics·Marco daCosta DiBonaventuraW Ray Kim
Oct 27, 2011·Journal of Hepatology·Valerie ByrnesNezam H Afdhal
Nov 26, 2011·Journal of Hepatology·Daniel M Forton
May 17, 2013·The New England Journal of Medicine·Scott D HolmbergMaxine M Denniston
Dec 10, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Zobair M YounossiSharon Hunt
Jan 28, 2014·Alimentary Pharmacology & Therapeutics·Z M YounossiS C Gordon
Apr 9, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiSharon L Hunt
Apr 12, 2014·The New England Journal of Medicine·Kris V KowdleyUNKNOWN ION-3 Investigators
Apr 15, 2014·The New England Journal of Medicine·Nezam AfdhalUNKNOWN ION-2 Investigators
Apr 15, 2014·The New England Journal of Medicine·Nezam AfdhalUNKNOWN ION-1 Investigators
Jul 16, 2014·Clinics in Liver Disease·Elizabeth C Verna
Aug 12, 2014·World Journal of Gastroenterology : WJG·Filippo AnsaldiGiancarlo Icardi
Oct 24, 2014·PloS One·Mychelle Morais-de-JesusLucas C Quarantini

❮ Previous
Next ❯

Citations

Nov 26, 2015·Expert Review of Gastroenterology & Hepatology·Marc BourlièrePhilippe Halfon
Mar 30, 2016·Mediators of Inflammation·Akihiro TamoriNorifumi Kawada
Feb 2, 2016·Journal of Hepatology·Graham R FosterUNKNOWN HCV Research, UK
Sep 28, 2015·Journal of Hepatology·Christophe Hézode, Jean-Pierre Bronowicki
Dec 15, 2015·Hepatology International·Kirat GillRobert Gish
Sep 1, 2015·Gastroenterology·Francesco NegroMichael P Manns
Sep 17, 2015·Journal of Hepatology·Jean-Michel PawlotskyUNKNOWN EASL Recommendations on Treatment of Hepatitis C 2015 panel. Electronic address: easloffice@easloffice.eu
Dec 25, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Elliot B Tapper, Michelle Lai
Dec 26, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sammy SaabNezam H Afdhal
Oct 29, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Nancy ReauKenneth E Sherman
Aug 13, 2015·Journal of Hepatology·Simon HjerrildPeter Leutscher
Sep 17, 2015·Journal of Hepatology·Lynn Gerber, Zobair Younossi
Jun 11, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tracey G Simon, Raymond T Chung
Aug 28, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Zobair M YounossiLinda Henry
Oct 7, 2016·Expert Review of Pharmacoeconomics & Outcomes Research·Linda Henry, Zobair Younossi
Mar 19, 2016·Journal of Gastroenterology and Hepatology·Raoel MaanCarin A Uyl-de Groot
Jan 5, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·Patrick Marcellin, Emilie Estrabaud
Sep 4, 2015·Therapeutic Advances in Gastroenterology·Brian P LamZobair M Younossi
Jan 25, 2017·Expert Review of Gastroenterology & Hepatology·Fabienne MarcellinMaria Patrizia Carrieri
Sep 29, 2017·Journal of Pediatric Gastroenterology and Nutrition·Zobair M YounossiSharon Hunt
Oct 17, 2017·Alimentary Pharmacology & Therapeutics·E OgawaUNKNOWN Kyushu University Liver Disease Study (KULDS) Group
Dec 2, 2017·Journal of Viral Hepatitis·Z M YounossiS Hunt
Dec 23, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Zobair M YounossiMarc Bourliere
Nov 7, 2018·Journal of Viral Hepatitis·Zobair YounossiAngelos Hatzakis
Oct 17, 2018·European Journal of Gastroenterology & Hepatology·Kathrin KrügerUNKNOWN Collaborators DHC-R
Feb 1, 2019·Journal of Clinical Gastroenterology·Zobair M YounossiLinda Henry
Jul 18, 2019·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Elfi EgmondRocio Martin-Santos
Sep 15, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·UNKNOWN AASLD-IDSA HCV Guidance Panel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.